Assessing prognosis in heart failure: Is hepatocyte growth factor the next B-type natriuretic peptide?

American Heart Journal

Volumn 150, Issue 1, 2005, Pages 1-3

  Katz, Jason N ^b   Drazner, Mark H ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CASPASE; CELL SURFACE RECEPTOR; CYSTATIN C; CYTOKINE; DNA FRAGMENT; ENDOTHELIN 1; GLYCOPROTEIN; MESSENGER RNA; PROTEIN BCL 2; PROTEIN BCL XL; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; TROPONIN;

ANGIOGENESIS; APOPTOSIS; CELL DEATH; CELL GROWTH; CELL MOTILITY; CHROMATIN CONDENSATION; ECHOCARDIOGRAPHY; EDITORIAL; GENE TRANSFER; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; METASTASIS; MITOGENESIS; MORPHOGENESIS; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT;

APOPTOSIS; BIOLOGICAL MARKERS; HEART FAILURE, CONGESTIVE; HEPATOCYTE GROWTH FACTOR; HUMANS; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; RISK ASSESSMENT;

EID: 23244461851     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2005.03.046     Document Type: Editorial

References (37)

1. M.H. Drazner, J.E. Rame, and L.W. Stevenson Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure N Engl J Med 23 2001 574 581
2. L.W. Stevenson, J.H. Tillisch, and M. Hamilton Importance of hemodynamic response to therapy in predicting survival with ejection fraction less than or equal to 20% secondary to ischemic or nonischemic dilated cardiomyopathy Am J Cardiol 66 1990 1348 1354
3. M.A. Quinones, B.H. Greenberg, and H.A. Kopelen Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy. Studies of Left Ventricular Dysfunction J Am Coll Cardiol 35 2000 1237 1244
4. D.M. Mancini, H. Eisen, and W. Kussmaul Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure Ciculation 83 1991 778 786
5. K.D. Aaronson, J.S. Schwartz, and T.M. Chen Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation Circulation 95 1997 2660 2667
6. T. Tsutamoto, A. Wada, and K. Maeda Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1 Eur Heart J 20 1999 1799 1807
7. J.N. Cohn, G.R. Johnson, and R. Shebetai Mechanistic data from the VA Cooperative Studies: ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart Circulation 87 Suppl 6 1993 VI5 VI16
8. C. Fisher, C. Berry, and L. Blue N-terminal pro B type natriuretic peptide, but not the new putative cardiac hormone relaxin, predicts prognosis in patients with chronic heart failure Heart 89 2003 879 881
9. T.B. Horwich, J. Patel, and W.R. MacLellan Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure Circulation 108 2003 833 838
10. R. Van Beneden, O. Gurne, and P.L. Selvais Superiority of big endothelin-1 and endothelin-1 over natriuretic peptides in predicting survival in severe congestive heart failure: 7-year follow-up study J Card Fail 10 2004 490 495
11. M.G. Shlipak, R. Katz, and L.F. Fried Cystatin-C and mortality in elderly persons with heart failure J Am Coll Cardiol 45 2005 268 271
12. W.H. Yin, L.W. Chen, and H.L. Jen Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure Am Heart J 147 2004 931 938
13. N. Lamblin, S. Susen, and J. Dagorn Prognostic significance of circulating levels of angiogenic cytokines in patients with congestive heart failure Am Heart J 150 2005 137 143
14. H. Arakawa, U. Ikeda, and Y. Hojo Decreased serum vascular endothelial growth factor concentrations in patients with congestive heart failure Heart 89 2003 207 208
15. B.S.P. Chin, A.D. Blann, and C.R. Gibbs Prognostic value of interleukin-6, plasma viscosity, fibrinogen, von Willebrand factor, tissue factor and vascular endothelial growth factor levels in congestive heart failure Eur J Clin Invest 33 2003 941 948
16. T. Nakamura, T. Nishizawa, and M. Hagiya Molecular cloning and expression of human hepatocyte growth factor Nature 342 1989 440 443
17. T. Nakamura, K. Nawa, and A. Ichihara Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats Biochem Biophys Res Commun 122 1984 1450 1459
18. G.K. Michalopoulos, K.A. Houck, and M.L. Dolan Control of hepatocyte replication by two serum factors Cancer Res 44 1984 4414 4419
19. P. Boros, and C.M. Miller Hepatocyte growth factor: a multifunctional cytokine Lancet 345 1992 293 297
20. R. Zarnegar, and G.K. Michalopoulos The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis J Cell Biol 129 1995 1177 1180
21. T. Soeki, Y. Tamura, and H. Shinohara Serum hepatocyte growth factor predicts ventricular remodeling following myocardial infarction Circ J 66 2002 1003 1007
22. S. Yasuda, Y. Goto, and T. Baba Enhanced secretion of cardiac hepatocyte growth factor from an infarct region is associated with less severe ventricular enlargement and improved cardiac function J Am Coll Cardiol 36 2000 115 121
23. H. Ueda, T. Nakamura, and K. Matsumoto A potential cardioprotective role of hepatocyte growth factor in myocardial infarction in rats Cardiovasc Res 51 2001 41 50
24. V. Jayasankar, Y.J. Woo, and T.J. Pirolli Induction of angiogenesis and inhibition of apoptosis by hepatocyte growth factor effectively treats postischemic heart failure J Card Surg 20 2005 93 101
25. K. Kitta, R.M. Day, and T. Ikeda Hepatocyte growth factor protects cardiac myocytes against oxidative stress-induced apoptosis Free Radic Biol Med 31 2001 902 910
26. W.S. Colucci Molecular and cellular mechanisms of myocardial failure Am J Cardiol 80 1997 15L 25L
27. D. Wencker, M. Chandra, and K. Nguyen A mechanistic role for cardiac myocyte apoptosis in heart failure J Clin Invest 111 2003 1497 1504
28. G. Olivetti, R. Abbi, and F. Quaini Apoptosis in the failing human heart N Engl J Med 336 1997 1131 1141
29. A.B. Gustafsson, and R.A. Gottlieb Mechanisms of apoptosis in the heart J Clin Immunol 23 2003 447 459
30. D. Engel, R. Peshock, and R.C. Armstrong Cardiac myocyte apoptosis provokes adverse cardiac remodeling in transgenic mice with targeted TNF overexpression Am J Physiol Heart Circ Physiol 287 2004 H1303 H1311
31. T. Nakamura, S. Mizuno, and K. Matsumoto Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF J Clin Invest 106 2000 1511 1519
32. V. Jayasankar, J. Woo, and L.T. Bish Gene transfer of hepatocyte growth factor attenuates postinfarction heart failure Circulation 108 Suppl. 1 2003 II230 II236
33. Y. Wang, N. Ahmad, and M.A. Wani Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis J Mol Cell Cardiol 37 2004 1041 1052
34. I. Ahmet, Y. Sawa, and K. Iwata Gene transfection of hepatocyte growth factor attenuates cardiac remodeling in the canine heart: a novel gene therapy for cardiomyopathy J Thorac Cardiovasc Surg 124 2002 957 963
35. Y. Li, G. Takemura, and K. Kosai Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice Circulation 107 2003 2499 2506
36. M.S. Sabatine, D.A. Morrow, and J.A. de Lemos Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes. Simultaneous assessment of troponin I. C-reactive protein, and B-type natriuretic peptide Circulation 105 2002 1760 1763
37. J. Ishii, W. Cui, and F. Kitagawa Prognostic value of combination of cardiac troponin T and B-type natriuretic peptide after initiation of treatment in patients with chronic heart failure Clin Chem 49 2003 2020 2026